chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient called 911 about 14 hours after receiving vaccine thinking she was having a heart attack (severe pain started in collar bones, moved to left side). EMS did not see anything wrong; patient waited to see if symptoms improved. Went into ER next morning when still having symptoms. ER did not find anything wrong, gave patient pain medication to help with pain. Patient has continued to have symptoms, even until recently still feeling unable to sleep on left side. Has since seen Dr. who has been treating for inflammation.
On 11/12/00, had fever of 105.3F, grunting and trouble breathing. Went to ER and treated with Augmentin.
p/vax pt devel rash, itching & swelling in AM 7/28/99;saw MD possible vaccine rxn given pred, zyrtec;
Pt recv vax on 8/25/98; one half hr later pt exp audible stridor, wheezing, runny nose, red-itchy eyes and rash around eyes.  Pt tx=Epinephrine .2cc (SC), vital signs taken, 911 called, Benadryl.  After 5 mins pt breathing was clear.
Following 2nd dose of Moderna vaccine, muscle aches, back pain, chills with joint aches.  The joint aches and muscle aches lasted for weeks following vaccine.
This case was reported by a healthcare professional and described the occurrence of irregular menstrual cycle in a 18-year-old female subject who was vaccinated with Havrix (GlaxoSmithKline). Concurrent vaccination included Gardasil (Merck; unknown given on 12 June 2007). On 12 June 2007 the subject received 1st dose of Havrix (unknown). In June 2007, at an unspecified time after vaccination with Havrix, the subject experienced irregular menstrual cycle. At the time of reporting the event was improved. The healthcare professional considered the event was possibly related to vaccination with Havrix.
rash all over; on her chest, arms, and neck; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: EN6207), via an unspecified route of administration, administered in right arm on 17Mar2021 at 12:00 (age at vaccination was 69-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history included Sjogren's syndrome (for 5 years and it was an autoimmune disease; took 2 medications) from an unspecified date of 2016 and high cholesterol. The patient's concomitant medications were reported as none. The patient previously took hydroxychloroquine sulfate (PLAQUENIL) and pilocarpine hydrochloride (SALAGEN); both for Sjogren's syndrome; and atorvastatin for high cholesterol. The patient did not receive any other vaccine within 4 weeks. On Mar2021, the patient experienced a rash all over; on her chest, arms, and neck. It was reported that the patient was trying to make an appointment with a dermatologist. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Lots pain, redness, large bruising in the area, trouble sleeping, intense burning at the site/ all in my upper arm area. pain has traveled into my underarm/swollen in that area, arm has become "numb" feeling,  losing grip strength, can hardly hold my 20 pound weight while working out when a 35 pound dumbbell was easy prior to this.  chest/back pain has gotten worse also.  It all started with the bruising and then the trouble sleeping. I listed my symptoms as they occurred.
Numbness in lower extremities, not able to walk independently, headaches, dizziness, hypertensive, sleeping 16+hours a day, and poor to no reflexes.
ON JUNE 10 , 2021  I DID HAVE A STROKE AND WAS TO THE HOSPITAL WITH THE AMBULANCE , I AM NOT SURE THAT IT WAS RELATED TO THE VACCINE WITH MODERNA .I WAS A HEALTHY PERSON EXCEPT HIGH BLOOD PRESSURE .
Initial report received from a health care professional (patient) on 27 October 2014. An adult female patient, had received a 0.5 ml single dose syringe of FLUZONE QIV vaccine (lot number: UI207AA, expiry date- 30 Jun 2015, dose number, route and anatomical side of administration was not reported) on 22 October 2014. The patient medical history and concomitant medications were not reported. On unknown date after vaccination patient had experienced injection site was really hot and red and it felt like a knot for about 3 days. Corrective treatment and laboratory details were not reported. At the time of this report, patient outcome was recovered on an unspecified date. Documents held by sender: None. Follow-up information received from a nurse (the patient) on 13 January 2015: On 22 October 2014, the patient aged 31 years, presented the events after administration of FLUZONE QIV intramuscularly. The patient had no illness at the time of vaccination and no pre-existing physician diagnosed allergies, birth defects and medical conditions. The patient did not receive any other medications. Laboratory data was reported as "observation".
Pt developed chickenpox subsequent to being exposed to a sibling who was vaccinated with varicella virus vaccine live. Follow up information received indicated that this is not believed to be a case of secondary transmission but of naturally occurring chickenpox.
None at time of vaccine known.  Reaction was 13 days later (potentially not related).  Patient tested positive for COVID-19 later the evening of reaction.
Within 24 hr of vax, pt devel redness, swelling itching & pain at inject site. Reporter indicates 7 pts exp this rxn. Additional reports to be generated.
itching, redness, and swelling on left shoulder about 4-5 inches in diameter. itching, redness, and swelling on right shoulder about 2 inches in diameter
Information has been received from a licensed practice nurse refers to an unspecified number of unspecified patients of unknown age and gender. The patients were administered doses of improperly stored VARIVAX (Merck) (dose, route and lot# were not reported) on unspecified dates since 26-FEB-2015. No adverse effect reported. It was unknown if the patients sought medical attention or not. At the time of report, the status of patients was unknown. This is one of the several reports received from the same reporter. Additional information has been requested.
Severe pain, soreness, limited movement and weakness in left arm.  No treatment.  Resulting in sleep disruption and having to leave my 20+ year carreer as a server in high end restaurants.
19NOV97 pt began to c/o tenderness & pain in spine, hips & knees;noticeable stiffness in movements & walking gait;no fever, h/a or rash noted;condition remains the same today 24NOV97;
Pt received flu then shingles vaccine, a few minutes later c/o increased HR. Sat at table started c/o difficulty swollowing and SOB. No  c/o chest pain. Nurse administered 0.4 mL epi into left deltoid. EMT called. Pt refused to go to ER, went home w husband.
Moderate soreness at injection site; Swelling and soreness of infraclavicular lymph node; Swelling and soreness of infraclavicular lymph node; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient received BNT162b2 (BNT162B2), on 17Feb2021 as dose 2, single (Lot number: EN6200) at the age of 70 years for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot number: EL9262), administration date: 28Jan2021, when the patient was 69-year-old, for COVID-19 immunization, reaction(s): "Moderate soreness at injection site", "Swelling and soreness of infraclavicular lymph node", "Swelling and soreness of infraclavicular lymph node". The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Moderate soreness at injection site"; LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious), outcome "unknown" and all described as "Swelling and soreness of infraclavicular lymph node".; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300118435 same patient, different dose, same events;
"Patient with 3 COVID vaccines who admitted to hospital with COVID detected PCR and complications of COVID who subsequently died of COVID complications.  Hospice provider consult note (patient died prior to admission to hospice):  ""86 YO female with a past medical history of mild chronic obstructive pulmonary disease, prior lung cancer status post LUL resection, scleroderma, Sjogren's syndrome.  Followed with Dr. outpatient.  Presented with fever, dyspnea and chest pain and admitted with diagnosis of COVID-19 and acute hypoxic respiratory failure.  She continued worsening inpatient with increased oxygen requirement.   Care service is now asked to see the patient for goals of care.     At time of initial consult she is on high-flow nasal cannula oxygen 40 liters/minute at 90%.  Per family report she is much more greatly fatigued today than previously.  She has asked several family members to just let me go and I do not want to do this anymore.    IMPRESSIONS / PLAN:   Care Issues: Conversion to comfort directed end of life care   1. Medical decision making capacity:  At the time of our consult the patient has limited ability for participation and medical decision making due to being in extremis.  Recent history of encephalopathy over past few days.  Neurology had evaluated as multifactorial metabolic encephalopathy. There are documents. Medical power of attorney 1.  Is husband 2. Is daughter   2. Goals of Care:  medical team had several meetings with family members today.  First meeting today involved daughter,  with myself and medical care chaplain. We shared some of the prognostic information from consultants and primary medical team.  Shared likely end of life trajectory given her acute on chronic respiratory failure.  Shared the ethics of decision making involving the patient's previously expressed personal wishes, including stating that she wanted to stop with aggressive care.  Discussed a reasonable plan for symptom management and the burdens and benefits of symptom management at end of life, including down and off titration of high-flow nasal cannula oxygen.  Another meeting was held this afternoon with myself, again daughter, and brothers.  The patient's husband, is present however he prefers to stay at the wife's bedside.   Comfort-directed End of Life care   3. Code Status:  No CPR/DNI/comfort 4. Psychosocial and Spiritual Support: Chaplain was present at family meeting today and religious priest was called by hospital chaplain this afternoon 5. medical care follow up :  medical Care will help to place comfort care orders.   Also placed hospice referral order and asking liaison to get hospice consent signed.  We can begin the process of admitting.  Family has already agreed to that plan.
headache; low fever; This case was reported by a consumer via call center representative and described the occurrence of headache in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd March 2020, the patient received the 1st dose of Shingrix. In March 2020, less than a week after receiving Shingrix, the patient experienced headache and fever. On an unknown date, the outcome of the headache and fever were unknown.   It was unknown if the reporter considered the headache and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group of the patient was not reported but it was selected as adult as per vaccine indication. The patient experienced low fever. The patient asked if it was contagious to a chemo patient.
small shingles on my back; itchy; burn pain / hate the burning pain I thought it was a spider bite; it blister up a Lil; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles, pruritus, pain burning and blister. On an unknown date, the outcome of the shingles, pruritus, pain burning and blister were unknown.   It was unknown if the reporter considered the shingles, pruritus, pain burning and blister to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient himself/herself. The age at vaccination was not reported. The patient had shingles previously before getting the current shingles and patient stated that the previous shingles was worse than current one. The patient received the 1st dose of Shingles vaccine and patient experienced small shingles on back. The reporter mentioned that the shingles was itchy and burn pain. The patient would go for his/her 2nd dose in September. The patient stated that he/she hate burning pain and stated that he/she thought it was spider bite first but it blister up lil.
Petechiae->purpura, DX:  Idiopathic thrombocytopenic purpura or erthema multiforme, had T of 101-102, runny eyes, measles type rash starting 1FEb con't into above symptoms 2Feb /w purpura on 3Feb.
Vaccine given at 1:48 PM. After administration, it was noticed that vaccine had expired on 05/14/2023.
Pt arrived to the hospital with weakness and congestion. He reports a cough for a month. Pt was tested for COVID and was positive and was admitted for sepsis from post COVID pneumonia.
patient that was under 18 that has received the vaccine/ 17 year and 9 months old received the 1st dose of the Moderna vaccine; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient that was under 18 that has received the vaccine/ 17 year and 9 months old received the 1st dose of the Moderna vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient that was under 18 that has received the vaccine/ 17 year and 9 months old received the 1st dose of the Moderna vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient that was under 18 that has received the vaccine/ 17 year and 9 months old received the 1st dose of the Moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment medications was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: Patient age was 17 years was received first dose of Moderna Vaccine on 29-Mar-2021
This spontaneous report as received from a nurse, refers to a patient of unknown age and gender. The nurse reported that on an unknown date, the patient was administered expired M-M-R II (dose, route, lot number and expiration date unspecified). No adverse event reported. Concomitant medications were not reported. Additional information is not expected.
This medically confirmed spontaneous report (initial receipt: 10-Jul-2012) concerns a female patient. On an unknown date the patient received a flu vaccine (brand name and manufacturer not reported) for vaccination. After administration of the flu vaccine, the patient developed a 'head to toe rash' as well as nose and lip swelling. The patient was seen immediately by her physician and 'given a shot'. The patient fully recovered.
No other AEs or PQC reported; administered after temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of an unspecified age and gender. The patient's medical history, concurrent conditions, concomitant medications, previous drug reactions or allergies were not provided.  On 01-OCT-2021, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U015689, expiration date was reported as 13-MAY-2023, however upon internal validation, it was established as 18-MAY-2023, 0.5 ml, subcutaneously (sq) for prophylaxis (strength was not provided).  It was stated, that the vaccine before administration was stored at the temperature of 25.9 Fahrenheit degree (F) for 1 hour and 30 minutes (improper storage of product in use). No previous temperature excursion was detected. It was not specified, if the data logger was involved. No other adverse events (AEs) or product quality complaint (PQC) were reported (no adverse event).
On the same day I got the vaccine and the next day, I had fever, body aches, and malaise; I was in bed for 2 days. I had a lack of energy that was worse than it had been before the vaccine. On or about 4/14/2021, I woke up at about 2:00AM with chest pain, pain in the left shoulder and in the left side of the neck. The symptoms subsided after some time. I had low oxygen saturation levels; I knew this, because I used a pulse oximeter that had been used by my late husband. The low oxygen saturation levels have been ongoing ever since, and I have had periods of rapid heart rate and oxygen levels that are even lower than the low levels I have experienced since the vaccine. I have also had periods of chest pains at times, so my PCP referred me to both a pulmonologist and a cardiologist.
Reports on 12/24/2020 noting a knot at the injection site and reports "my arm hurting" through 12/27/2020. 12/25/2020 - 12/26/2020 she c/o of headache, dizziness, "everything hurt under the sun".  12/29/2020 develops runny nose, sinus congestion. She was tested for Covid on 12/29/2020 and was found to be positive. From 12/31/2020 to 1/5/2021 she had fevers from 99-101. on 1/6/2021 she began having diarrhea and increased fatigue. On 1/6 she developed SOB, was in contact with PCP clinic where she was instructed to push fluids and use Incentive Spirometry. On 1/8/2021 she is seen in the local ER with c/o increased SOB with activity and fells like she cannot cleat congestion from her chest with coughing.
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 09/10/2021. PATIENT FULLY VACCINATED ON 03/23/1997.
Elevated D Dimer noted on routine visit to hematologist. DVT in LT calf confirmed by doppler study. Started taking Xarelto and continues to take Xarelto 20mg QD at present
I had stuffy head, cough, runny nose, watery eyes, I made an appointment to see my doctor, who did an exam. Upon examining my ears, she said the pressure I was experiencing was from a sinus infection. She gave me a steroid shot before leaving the office, wrote me prescriptions for a Z-PAK, and MUCINEX-D.
Sudden onset of chest pain with tightness (elephant sitting on chest) shortness of breath, weakness, diaphoresis. Patient stated she had panic attacks. Cardiac enzymes, EKG, & Chest X-ray was performed in the ED. ASA was given PO. Patient refused admission for observation or to complete lab studies of second myoglobin.
body aches; headache; This is a spontaneous report received from a contactable reporter (Pharmacist).  A male patient in his 60's received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (DOSE 1, SINGLE), for COVID-19 immunisation. The following information was reported: PAIN (non-serious), outcome "recovering", described as "body aches"; HEADACHE (non-serious), outcome "recovering", described as "headache". Additional information: Clinical course: Shot received at 10 AM and symptoms set in later in day, lasting through next morning before beginning to resolve.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Friday evening 10-21-16 pt. shot area was firm-by Saturday 10-22-16 Quarter size red spot and by Sunday bright red "baseball" size red spot-firm to touch with white ring around shot area-area also slightly swollen as reported by mother.
About 10 days later around 12/10/2021, I was travelling and I had: I was hiking and had what I thought was environmental issues, I was hiking and there were cacti and all these plants I was not used to be around. I had contact with a cactus flower, I thought I had a reaction to this plant. December came and went, then January and in February I had continued having blisters and pealing on the palms of my hands and bottom of my feet. I thought it was triggered by the cactus. My regular doctor did not know what it was so he sent me to my dermatologist, He stated you do not have a reaction to the plant, it is an auto immune disease that you will probably have forever. It is called Palmoplantar Psoriasis. The problem is not the plant it is your immune system. He is treating me for this condition I did not know about. I don't know if you need to know this but I am loosing my fingernails also. My concern is that this all happened within close proximity to the vaccine. The doctor is currently treating me with strong topical cortisone cream which has helped with the pain and has caused everything to calm down some. This is all very embarrassing with loosing my fingernails.
pt recv vax & pt presented to ER w/hives on neck;pt was tx w/DPH & calamine lotion w/no relief;
I don't know if it had anything to do with the injection. I had extreme vertigo, I couldn't sit up, stand up and got very nauseas. It started at 3:30 am and I was taken by ambulance to the hospital at noon. By 1pm I was not better but out of the vertigo.
Post vaccination, patient c/o chest tightness and throat swelling while in observation area.  BP150/70  HR: 84 POx: 98% on room air.  Patient was given 50mg of PO Benadryl with not relief.  Patient then received Epinephrine 0.3mg IM.  911 called.  Patient states that chest tightness had improved but was still present.  Husband called.  Patient transported to ER in stable condition
Information has been received from a physician concerning a kid who was vaccinated with a dose of varicella virus vaccine live.  On approximately 25-FEB-2006 the patient experienced varicella breakthrough.  Unspecified medical attention was sought.  There was no product quality complaint involved.  Additional information has been requested.